Prestige Consumer Healthcare Inc. (PBH)

Market Cap	4.19B
Revenue (ttm)	1.12B
Net Income (ttm)	213.94M
Shares Out	49.54M
EPS (ttm)	4.26
PE Ratio	19.87
Forward PE	17.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	294,102
Open	85.60
Previous Close	84.79
Day's Range	84.20 - 86.03
52-Week Range	62.35 - 88.36
Beta	0.50
Analysts	Strong Buy
Price Target	93.25 (+10.19%)
Earnings Date	Feb 6, 2025

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Feb 10, 2005
• Employees: 570
• Stock Exchange: NYSE
• Ticker Symbol: PBH
• Website: https://www.prestigebrands.com

Analyst Forecast

According to 4 analysts, the average rating for PBH stock is "Strong Buy." The 12-month stock price forecast is $93.25, which is an increase of 10.19% from the latest price.

Price Target

$93.25

(10.19% upside)

Analyst Consensus: Strong Buy